Although DNA damage is considered a driving force for aging, the nature of the damage that arises endogenously remains unclear. Replicative stress, a source of endogenous DNA damage, is prevented primarily by the ATR kinase. We have developed a mouse model of Seckel syndrome characterized by a severe deficiency in ATR. Seckel mice show high levels of replicative stress during embryogenesis, when proliferation is widespread, but this is reduced to marginal amounts in postnatal life. In spite of this decrease, adult Seckel mice show accelerated aging, which is further aggravated in the absence of p53. Together, these results support a model whereby replicative stress, particularly in utero, contributes to the onset of aging in postnatal life, and this is balanced by the replicative stress-limiting role of the checkpoint proteins ATR and p53.
The accumulation of DNA damage can have important consequences that limit the lifespan of mammalian organisms, such as aging or cancer. Concerning aging, one current theory is based on the accumulation of DNA damage 1 . In accordance with this theory, signals indicating activation of the so-called DNA damage response (DDR) have been shown to increase in aged tissues and stem cells 2, 3 , and several mouse models with impaired DNA repair show features of premature aging 4 . Concerning cancer, DNA damage is the source of mutations that drive malignant transformation. Therefore, it is not surprising that organisms have evolved complex signaling pathways to protect their DNA. In particular, the DDR starts with the activation of either one of two members of the PIKK family of protein kinases: Ataxia Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and Rad3-related (ATR) 5 . Whereas ATM is activated by DNA doublestrand breaks (DSBs), ATR responds to single-stranded DNA (ssDNA) both at resected DSBs and at aberrant replicative structures that compromise genome integrity during the S phase of the cell cycle. Regardless of the kinase that initiates the signaling, the final outcome of the DDR is to promote DNA repair while delaying cell cycle progression until chromosomes are repaired.
Whereas ATM-deficient mice were generated more than a decade ago [6] [7] [8] , efforts to decipher the physiological roles of ATR have been hampered by the essential nature of this kinase 9, 10 . However, although complete knockout of Atr is lethal, a seminal study found a hypomorphic mutation in humans with a rare disease known as Seckel syndrome (MIM210600) 11 . This disease was first described by Helmut Seckel in 1960 as ''bird-headed dwarfism'' because of the severe dwarfism and craniofacial features of those affected 12 . In homozygosity, the mutation introduces a splicing defect that reduces the abundance of ATR to almost undetectable, yet the remaining protein is sufficient for viability. We have here exploited the human ATR-Seckel mutation to generate a viable model for the study of ATR function in mammals.
RESULTS

Strategy to develop a mouse model of Seckel
One of the mutations that has been linked to Seckel syndrome is a synonymous A4G transition in exon 9 of the ATR gene 11 . The mutation promotes the skipping of this exon during the splicing reaction, which results in a severe ATR hypomorphism. We decided to use this information to generate a mouse model of the human disease. We reasoned that because the Seckel mutation affects splicing, the introns and splicing donor/acceptor sequences encompassing ATR exon 9 were likely to be necessary to recapitulate the molecular defect. Thus, our strategy was to swap the entire mouse genomic fragment encompassing exons 8, 9 and 10 with the human counterpart and then introduce the Seckel mutation to the humanized mouse allele (ATR S ; Fig. 1a,b) . ATR S/S mouse embryonic fibroblasts (MEFs) showed a severe splicing deficiency of the humanized transcript at the exon 8-10 region that led to a deficit of ATR protein comparable to that observed in human ATR-Seckel cells (Fig. 1c-f) . Sequencing of the main splicing product of ATR S/S MEFs revealed that it corresponded to an aberrant transcript that had skipped exon 9. Thus, the molecular behavior of the humanized mouse allele faithfully recapitulated that of the mutant ATR gene previously linked to Seckel syndrome.
Recapitulation of Seckel syndrome in ATR S/S mice ATR S/S mice were born at submendelian ratios (w 2 , P o 0.0001; 31.8% Atr +/+ , 57.8% ATR S/+ , 10.4% ATR S/S ) and showed severe dwarfism that was already noticeable at birth ( Fig. 2a-d ). Of note, mutant placentas showed an accumulation of necrotic areas and overall loss of cellularity, which could also contribute to the dwarf phenotype regardless of intrinsic developmental defects (data not shown). In addition to the overall dwarfism, Seckel mice showed a disproportionate decrease in the dimensions of their heads, or microcephaly ( Fig. 2e and Supplementary Fig. 1) . Notably, the heads of the mutant mice were not only small but also dysmorphic, showing the micrognathia and receding forehead characteristic of the human disease ( Fig. 2f and Supplementary Fig. 1 ). While acknowledging the obviously different facial features of mice and humans, we note that the receding forehead phenotype led to the appearance of a protruding nose in ATR S/S mice, which is reminiscent of the ''bird-head'' phenotype that gave the original name to the disease (Fig. 2e) .
Consistent with the microcephaly, Seckel mice showed a reduction in the size of their brains ( Supplementary Fig. 2a) . Moreover, magnetic resonance imaging (MRI) analyses revealed profound abnormalities on ATR S/S brains such as the presence of cysts (6/8 mice analyzed) and agenesis of the corpus callosum (AgCC, 8/8 mice) (Fig. 2g) . These MRI scans are notably similar to those previously obtained from humans with Seckel syndrome 13 . Consistent with the AgCC, histology revealed a severe loss of astrocytes at the corpus callosum of the mutant mice ( Supplementary Fig. 2b ). Together, these findings suggest that the ''bird-head'' appearance of humans with Seckel syndrome derives from a primary developmental defect in the formation of the brain.
Besides the brain, several organs were noticeably smaller in the mutant mice ( Supplementary Fig. 3a ). Whereas at birth ATR abundance was reduced in all organs, this difference became postnatally attenuated in some of them such as the testes or lungs (Supplementary Fig. 3b ). This might represent a selection for cells in which the percentage of productive splicing is highest, which will particularly occur in tissues with high replicative indexes. Regardless of its origin, the recovery in ATR abundance suggests an essential role for even minimal amounts of the protein in these organs, as recently described for spermatogenesis in studies performed with a conditional Atr allele 14 .
The recovery of ATR abundance suggests that the organs in which this was seen could gain a proficient ATR response by adulthood. Accordingly, in vitro fertilization could be successfully completed with ATR S/S sperm (data not shown). In contrast, given that all proliferation linked to oogenesis takes place in the embryo, female gametogenesis would not allow postnatal selection for ATR abundance, and a meiotic defect might persist in the adult. Indeed, we obtained no viable oocytes even after hormone-induced superovulation of the mutant mice, and ATR S/S ovaries showed a near-complete absence of maturing oocytes ( Supplementary Fig. 4a ). Although newborn ATR S/S ovaries carried abundant primordial follicles, a high proportion of them were degenerating, which likely indicates a meiotic recombination defect and would explain the later absence of oocytes in the adult ( Supplementary Fig. 4b,c) . None of the phenotypes found in ATR S/S mice were observed in a control strain that carried the same humanized allele without the Seckel mutation (Fig. 2h,i and Supplementary  Fig. 5 ). And although some of the phenotypic manifestations we observed in ATR S/S mice were in addition to those known in humans, these mice recapitulated all the criteria that are used in the clinic for the diagnosis of Seckel syndrome, including the ''bird-headed dwarfism'' that originally named the disease.
Development of a progeroid phenotype in Seckel mice
Seckel mice died in less than half a year, showing cachexia and several phenotypes associated with aging, including hair graying, kyphosis, osteoporosis, accumulation of fat in the bone marrow, decreased density of hair follicles and thinner epidermis (Fig. 3a-d and data not shown). Analysis of peripheral blood revealed pancytopenia, with decreased numbers of red, white and platelet cells, as it has been reported in humans with Seckel syndrome (Fig. 3e) 15 . Altogether, these phenotypes indicate the development of a progeroid syndrome in Seckel mice.
To evaluate whether the aging phenotype was linked to stem cell dysfunction, and due to the presence of pancytopenia, we focused on the hematopoietic stem cell (HSC) compartment-one that is well understood and whose dynamics have been analyzed in relationship to aging 16 . A first indication of a dysfunctional HSC compartment was a general decrease in cellularity and accumulation of fat on ATR S/S bone marrow, which is also observed during normal aging 17 . The analysis of the HSC compartment of the Seckel mice showed similar features to those previously observed in aged mice or humans ( Supplementary  Fig. 6a-c) . First, the frequency of LSK (Lin -Sca1 + Kit + ) cells was low in the bone marrow of Seckel mice. Second, within the mutant LSK population, the fraction of long-term HSCs was high and that of multipotent progenitors low 18, 19 . In summary, the HSC compartment of young ATR S/S mice resembled that of aged animals.
To determine whether the altered frequencies of ATR S/S HSCs were due to cell-autonomous effects, we performed mixed bone-marrow reconstitution experiments into irradiated wild-type (WT) hosts. In contrast to other mouse models deficient in DNA repair 3 Seckel bone marrow to be equivalent to WT bone marrow in its capacity to reconstitute the granulocyte compartment, and it was also able to substantially reconstitute the lymphocyte compartment (Supplementary Fig. 6d ,e). As ATR S/S HSCs showed repopulating potential when injected into a WT host, but ATR S/S mice developed pancytopenia, non-cell-autonomous factors, such as the deterioration of stem cell niches, must account for the altered function of the HSCs within the mutant mice. The degeneration of the bone marrow in ATR S/S mice also supports this notion that stem cell niches are compromised. Accordingly, reconstitution of Seckel mice with WT bone marrow did not restore normal thymus size (data not shown). In summary, the presence of pancytopenia in ATR S/S mice derives from altered HSC frequencies that resemble those found in aging, which likely result from the degeneration of the niche that supports their function. Recent studies have shown that human aging triggers a molecular signature characterized by a dampening of the insulin-like growth factor-1-growth hormone (IGF-1/GH) somatotroph axis 20, 21 , and which is also found in mouse models of progeria 22, 23 . Transcriptional profiling of livers and brains of 3-month-old mice revealed such a hallmark in ATR S/S tissues ( Supplementary Fig. 7 ). But although the dampening of the IGF-1/GH pathway can also be induced in mice by genotoxic agents 22,23 , we did not find a significant increase in the amount of endogenous DNA damage in these organs in postnatal life. This is particularly telling in the case of the brain because, given its nonreplicative nature, ATR should have a limited role in this organ in protecting against postnatal replicative stress. Altogether, our animal, cellular and molecular data demonstrate that the introduction of the Seckel mutation in the mouse led to the development of a progeroid syndrome that limited the lifespan of the animals.
Embryonic ATM/DNAPK-dependent DDR One possible way to reconcile the dampening of IGF-1/GH in the absence of contemporaneous DNA damage is that this transcriptional program may have been initiated in response to an exposure to DNA damage at a previous stage. To determine the behavior of embryonic cells, we analyzed Atr +/+ and ATR S/S MEFs. Like human Seckel cells 11 , ATR S/S MEFs were sensitive to ultraviolet or methyl methanesulfonate (Fig. 4a-c) . Nonetheless, even if they were not exposed to exogenous damage, proliferation of Seckel MEFs decreased sharply and mutant cells rapidly entered senescence (Fig. 4d) . This occurred regardless of whether the cultures were maintained under normoxic (3% O 2 ) conditions (data not shown). The growth arrest was concomitant with an accumulation of cells in G2, suggesting an activation of the DDR due to replicative damage (Fig. 4e) . Accordingly, a high percentage of ATR S/S MEFs showed pan-nuclear staining for the phosphorylated form of histone H2AX (gH2AX) (Atr +/+ , 0%; ATR S/S , 7.6 ± 2.3%) (Fig. 4f) . In contrast to gH2AX foci, the pan-nuclear staining of gH2AX was equivalent to that caused by inducers of replicative stress, such as hydroxyurea, and occurred only in cyclin A-expressing cells (data not shown). Many of the mutant cells also showed p53-binding protein-1 (53BP1) foci, indicative of DSBs. Moreover, ATR S/S metaphases had a high frequency of chromosomal breakage which, consistent with the known role of ATR in maintaining the stability of stalled replication forks [24] [25] [26] and suppressing fragile site expression 27, 28 , frequently occurred at fragile sites ( Fig. 4g-i) . Thus, the Seckel MEFs were unable to sustain proliferation ex vivo because of the activation of a replicative stress-initiated DDR.
We then investigated which kinase was responsible for activating the DDR in ATR S/S MEFs. A combined treatment with inhibitors of ATM and of the DNAdependent protein kinase catalytic subunit (DNAPKcs) virtually eliminated the gH2AX signal-and 53BP1 foci-in Seckel cells (Fig. 5a,b) . We thus tested whether the use of the inhibitors could alleviate the growth arrest. However, whereas treatment with the inhibitors abrogated the G2 arrest (Fig. 5c) , this did not restore growth. On the contrary, ATM and DNAPKcs inhibitors were particularly toxic for Seckel MEFs (Fig. 5d) . Consistent with the synthetic lethal effects observed in vitro, ATM deficiency led to embryonic lethality when combined with the ATR S/S genotype (data not shown). In summary, the severe downregulation of ATR in MEFs leads to the activation of an ATM-and DNAPKcs-dependent DDR in replicating cells owing to an accumulation of replicative stress.
Accumulation of replicative stress in Seckel embryos
We then evaluated whether evidence of replicative stress could also be detected in vivo. To this end, gH2AX distribution was analyzed in 13.5 days post coitum (d.p.c.) embryos (Supplementary Fig. 8 ; Fig. 6a ). Whereas almost no gH2AX is normally detected in WT embryos, ATR S/S littermates showed an accumulation of cells with pan-nuclear gH2AX throughout the entire embryo. p53 and activated caspase-3 showed a similar distribution, as proof that many cells were being eliminated by apoptosis at this stage (Fig. 6b,c) . A similar analysis only revealed a marginal increase of replicative stress or apoptosis in tissues from adult mutant mice such as the brain, colon, proliferating B cells, stomach, liver, lung, kidneys, skin and heart ( Fig. 6d and data not shown) . This observation could reflect the high replicative activity of embryonic stages in contrast to adult tissues. One exception to this occurred in the brain, which undergoes a rapid proliferative burst in the first days of life. In this case, both embryonic and newborn brains showed apoptosis and replicative stress in the replicating areas (Fig. 7a-c) . In contrast, we observed no proliferation or differentiation defects (Fig. 7d) . It is likely that this particular proliferative expansion of the brain will contribute to the microcephaly of the mutant mice through the effects of replicative stress-driven apoptosis. Altogether, our data revealed that Seckel embryos show a generalized activation of an apoptotic DDR that, with the exception of the newborn brain, becomes marginal in postnatal life.
p53 deficiency accelerates aging in Seckel mice
Given the accumulation of p53 in Seckel embryos, we tested whether p53 deficiency could mitigate some of the aging phenotypes of ATR S/S mice. Unexpectedly, ATR S/S ; Trp53 À/À double-mutant mice were rarely born (1.02% from ATR S/+ Â Trp53 +/À crosses, n ¼ 294), and the few mice that were born showed a more severe progeroid syndrome than their ATR S/S ; Trp53 +/+ littermates ( Supplementary  Fig. 9 ). As a consequence, no ATR S/S ; Trp53 À/À mice survived for more than 2 months.
To determine the molecular mechanism by which p53 deficiency exacerbated the Seckel phenotype, we infected MEFs with control and Trp53 short hairpin RNA (shRNA)-expressing retroviruses. Whereas p53 downregulation in WT MEFs slightly increased their growth, it led to a loss of viability of the mutant cultures accompanied by massive nuclear abnormalities (Fig. 8a,b) . One possibility was that p53 loss could be driving G2-arrested cells to mitotic catastrophe. But to the contrary, p53 depletion in ATR S/S MEFs led to a further accumulation of cells in G2 as well as a fourfold increase in the number of cells showing pan-nuclear gH2AX staining, indicating that the increased growth rates associated with p53 loss had led to an increase of replicative stress on Seckel cells (Fig. 8c,d) . If p53 loss occurs in ATR-proficient cells, these cells should still be able to deal with the higher replication rates and to avoid the development of replicative stress. Accordingly, whereas Trp53 À/À embryos did not show evidences of replicative stress ( Supplementary Fig. 10 ), ATR S/S ; Trp53 À/À embryos showed a marked increase of cells with pan-nuclear gH2AX compared with their ATR S/S ; Trp53 +/+ littermates (Fig. 8e,f) . Moreover, p53 deficiency further increased the number of cells that were eliminated by apoptosis in Seckel embryos, which explains the increased dwarfism of the double-mutant mice (data not shown). In summary, the loss of p53 led to an increase in the amount of replicative stress suffered by Seckel embryos, which led to an aggravation of the Seckel phenotypes and further accelerated the onset of aging in ATR S/S mice.
DISCUSSION
The Seckel strain developed in this study recapitulates the human disease to a remarkable extent. In addition to the overall appearance, the previously reported observations of chromosomal instability 15, [28] [29] [30] , progeria or senile appearance 15, [31] [32] [33] and pancytopenia 15 were all present in Seckel mice. Characterization of this mouse model also suggests possible mechanisms for some of the Seckel syndrome phenotypes. These included a specific depletion of astrocytes at the corpus callosum as an explanation for the AgCC, the degeneration of the bone marrow and associated HSC dysfunction as the cause of pancytopenia, and the generalized activation of an apoptotic DDR in the embryo as an explanation for the dwarfism. Of particular relevance is the finding that microcephaly could be, at least in part, explained by the exponential replicative expansion that the brain undergoes in the first days of life, which makes it more susceptible to mutations that promote replicative stress. Seckel syndrome is a variegated disease that has been mapped to four different loci, from which only two genes-ATR and PCNT, encoding pericentrin-have been identified 11, 34 . The severity of the phenotypes might therefore differ from case to case. In addition to the phenotypes described above, individuals with ATR-Seckel syndrome have shown microcrania with fused sutures, dental malocclusion and deficient closure of the fontalelles 35 , all of which were frequent in ATR S/S mice (see Supplementary Fig. 2 ). Although no pancytopenia was reported, the subjects were infants at the time of analysis and such a symptom might develop later. Altogether, we believe the mouse mutant generated in this study constitutes a valid model for the investigation of Seckel syndrome in the laboratory.
In previously published progeroid models, DNA damage accumulates after birth 1, 3 . However, whereas we found a generalized activation of the DDR in ATR S/S embryos, we did not detect a similar increase of endogenous damage on adult tissues. On the basis of this observation, we propose that the accumulation of replicative stress in the embryo affects the future onset of aging and overall well being of the adult mice. This is supported by several arguments. First, organs that are highly proliferative in postnatal mice undergo a selection process so that ATR abundance in Seckel mice becomes close to that in WT. Thus, even if adult ATR S/S mice are ATR proficient in many of their regenerating organs, this does not prevent the onset of progeria. This is in agreement with the normal functioning of ATR S/S sperm or HSCs when transplanted into a WT host. Second, adult organs with embryonic replicative stress but no evidence of DNA damage in postnatal life show a transcriptional signature characteristic of 'aged' organs. Of note, this transcriptional response is activated by the exposure to DNA damage 22, 23 . Finally, even though the elimination of ATR in 1-monthold mice leads to the development of several progeroid symptoms 14 , some of these mice can survive for up to 19 months (E. Brown, personal communication). This comparison by itself strongly suggests that embryonic ATR deficiency substantially affects future lifespan. One possible way to explain this phenomenon is that the generalized loss of cells by apoptosis during embryogenesis can compromise future stem cell functioning, not only by limiting stem cell pools but particularly by an alteration of stem cell niches, as we have seen in the case of HSCs. Altogether, we propose that the generalized exposure to DNA damage in ATR S/S embryos is responsible for the initiation of a progeroid program that drives young animals into senescence.
The concept of embryonic dysfunction leading to problems in adulthood has previously been described as 'intrauterine programming' [36] [37] [38] . Among other things, intrauterine programming has been associated to the onset of type-2 diabetes, obesity, hypertension, cardiac dysfunction, kidney disorders, autoimmunity and osteoporosis. Since the 1920s, a decreased size of the head and brain accompanied by mental retardation has been known to be the main effect of fetal exposure to DNA damage 39 . Furthermore, intrauterine radiation leads to AgCC in Swiss mice 40 . Notably, the main consequence of prenatal exposure of rats to replicative stress-inducing agents such as hydroxyurea is the presence of several craniofacial malformations, including micrognathia, which is a hallmark of Seckel syndrome 40 . Nevertheless, these works evaluated the effects of acute intrauterine exposure to genotoxic agents, so it is likely that a prolonged exposure, as in the case of ATR S/S embryos, could lead to more prominent and lasting effects. We therefore suggest adding aging to the list of adult phenotypic manifestations that can arise as a consequence of intrauterine distress.
Previous mouse models of progeria have shown that the absence of p53 relieves some of the growth disadvantages and, if no cancer arises, enhances the lifespan of these animals 41 . Unexpectedly, we found here that p53 loss accelerates the aging of Seckel mice. The explanation for this phenomenon seems to lie in the effects of p53 on cell cycle progression. As some of the p53 targets, such as p21, are well known inhibitors of cyclin-dependent kinase activity 42 , it is reasonable to think that p53 loss might enable slightly faster replication. Whereas ATR-proficient cells might be able to cope with this, it would exacerbate the accumulation of replicative stress when ATR signaling is compromised. Notably, p53 loss further increased the amount of apoptosis of Seckel embryos, suggesting that replicative stress might be able to initiate p53-independent apoptotic pathways. Along these lines, a recent work revealed that loss of the checkpoint kinase Chk1 leads to p53-independent apoptosis in zebrafish 43 . Besides its implications for aging, the synthetic lethal effects of ATR and p53 suggest that ATR inhibitors could be explored for the selective elimination of p53-deficient tumors. Similarly, our results can also help to explain the increased sensitivity of p53-deficient tumors to UCN-01, a chemical inhibitor of the ATR target Chk1 (ref. 44) . It is reasonable to think that the synthetic lethal effects of ATR or Chk1 with p53 loss will also apply to other genetic changes that promote faster replication rates, as is the case in many cancerassociated mutations. In this regard, a recent report has shown that p21 loss in the context of an oncogene that generates replicationlinked DNA damage is tumor suppressive 45 . Thus, in the context of replicative stress, mutations that promote proliferation will boost replicative stress even further, which, if too high, can limit the viability of the cells. Of note, this is not the first evidence of an aging-suppressive function of the p53 response: transgenic mice carrying extra alleles encoding p53 and p19 ARF have been shown to have an increase in the median lifespan 46 . However, our data provide the first genetic evidence showing that p53 loss might promote aging in vivo.
Death of Seckel mice was associated with a generalized organ failure, with several organs showing phenotypes that are reminiscent of age-related dysfunction. Nevertheless, even though ATR has been shown to be a haploinsufficient tumor suppressor 47 , we detected no tumors in ATR S/S mice, even in the absence of p53. One potential explanation is that the toxic effects of high levels of replicative stress may counterbalance the mutagenicity of DNA breaks. In this manner, whereas a small reduction in ATR might promote cancer, a severe dampening of the ATR response might become tumor suppressive. Similarly, although Chk1 is a haploinsufficient tumor suppressor 48 , Chk1 inhibitors are now being used to kill cancer cells. One example of such a dichotomy is XPF, mild mutations in which increase cancer susceptibility, whereas mutations that further compromise activity promote progeria 23 .
In summary, we here present a mouse model of the ATR-Seckel syndrome that faithfully recapitulates the symptoms of the human disease and provides a viable model for genetic studies of ATR function in a mammal. Our study suggests a mechanism whereby Seckel arises as a consequence of the accumulation of replicative stress during embryonic development, which triggers an ATM-dependent DDR that affects phenotypes in the adult mice. We believe that incorporating aging into the battery of phenotypes that can be influenced by fetal distress might help to understand the variability of the aging process that is observed between individuals.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
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